Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2b study of redasemtide versus placebo in adults with acute ischemic stroke ineligible for thrombolysis or thrombectomy
MOH_2023-06-13_012739Phase 2Not yet recruiting
- Sponsor
- Shionogi & Co., Ltd.
- Start
- May 2023
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of redasemtide in ischemic stroke (3 arms), sponsored by Shionogi & Co., Ltd. Planned start May 2023; status: not yet recruiting.
02
Drugs
redasemtide
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on MOH_2023-06-13_012739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2023-06-13_012739.